Physicians' ability to predict patients' adherence to antihypertensive medication in primary care

Hypertension Research

Volumn 31, Issue 9, 2008, Pages 1765-1771

  Zeller, Andreas ^a   Taegtmeyer, Anne ^a   Martina, Benedict ^a   Battegay, Edouard ^a,b   Tschudi, Peter ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adherence; Compliance; Hypertension; Primary care; Visual analogue scale

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACCURACY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; ELECTRICAL EQUIPMENT; FEMALE; HUMAN; HYPERTENSION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PHYSICIAN ATTITUDE; PREDICTION; PRIMARY HEALTH CARE; SELF REPORT; VISUAL ANALOG SCALE;

EID: 55449088648     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1765     Document Type: Article

References (32)

1. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
2. Hansson L, Zanchetti A, Carruthers SG, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762.
3. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005; 353: 487-497.
4. Melnikow J, Kiefe C: Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994; 9: 96-105.
5. Urquhart J: Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 1996; 17 (Suppl A): 8-15.
6. Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA: Measuring adherence to behavioral and medical interventions. Control Clin Trials 2000; 21: 188S-194S.
7. Norell SE: Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med [E] 1981; 15: 57-61.
8. Gilbert JR, Evans CE, Haynes RB, Tugwell P: Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J 1980; 123: 119-122.
9. Bangsberg DF, Hecht FM, Clague H, et al: Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26: 435-442.
10. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL: Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. Aids 2002; 16: 1835-1837.
11. Miller LG, Liu H, Hays RD, et al: How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002; 17: 1-11.
12. Murri R, Ammassari A, Trotta MP, et al. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. J Gen Intern Med 2004; 19: 1104-1110.
13. Macintyre CF, Goebel K, Brown GV: Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses and patients compared with urine drug levels. Prev Med 2005; 40: 41-45.
14. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
15. Wetzels GE, Nelemans P, Schouten JS, Prins MH: Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004; 22: 1849-1855.
16. Paterson DL, Swindells S, Mohr J, et al: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
17. Svarstad BL, Chewning BA, Sleath BL, Claesson C: The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37: 113-124.
18. Zeller A, Schroeder K, Peters TJ: An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol 2008; 61: 282-288.
19. Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M: Determinants of poor adherence in hypertensive patients: development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire." Patient Educ Couns 2006; 64: 151-158.
20. Bailey JE, Lee MD, Somes GW, Graham RL: Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther 1996; 18: 1252-1262.
21. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM: Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307: 846-848.
22. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G: The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 2779-2781.
23. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
24. Fodor GJ, Kotrec M, Bacskai K, et al: Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens 2005; 23: 1261-1266.
25. Insull W: The problem of compliance to cholesterol altering therapy. J Intern Med 1997; 241: 317-325.
26. Wickstrom G, Bendix T: The "Hawthorne effect" - what did the original Hawthorne studies actually show? Scand J Work Environ Health 2000; 26: 363-367.
27. Urquhart J, De Klerk E: Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998; 17: 251-267; discussion 387-389.
28. Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W: The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11: 1403-1411.
29. McKenney JM, Munroe WP, Wright JT Jr: Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992; 32: 277-283.
30. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR: Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335-341.
31. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al: Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36: 1100-1102.
32. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR: Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004; 5: 74-79.